Trending Content - Equity Research Forum
| +13 | Is Equity Research Dying - Where Are the Future Opportunites? | 3 | 1h |
| +10 | Associates who stuck around for > 5 years working for the same analyst. Why? | 4 | 5d |
| +9 | UBS ER SA27 Superday | 7 | 3w |
| +9 | Detailed Revenue and Cost Builds | 3 | 1w |
| +7 | Uiuc or Ross or UChicago | 8 | 2w |
| +7 | Analyst with no coverage or ranking | 5 | 1w |
| +1 | IB SA -> ER FT | 4 | 1w |
| 0 | Equity Research Rankings | 1 | 1w |
Career Resources
Most fintechs want to be valued like software or payments companies. So the goal is to have recurring revenue or take rate revenue models (or both). Saw extremely high multiples in 2021 like well over 20x revenue. Look at the performance of recently public fintech companies, though. Getting completely battered and some are off 60-90% from IPO price. (E.g., Hippo, an insurtech)
Multiple compression in private markets has lagged but every fintech startup internally knows they'd raise flat or down in this environment. Seeing much more aggressive stipulations on term sheets like higher liquidation preference, participation, cumulative dividends etc. You’re going to see the effects of a 2023 round on these cap tables for years.
I would bet two things.
Aut culpa consequatur similique eum. Voluptas molestias cumque architecto suscipit ad. Saepe et earum qui harum vero.
Doloribus expedita pariatur sunt eos ut magni. Vel dolorem et veritatis impedit inventore autem quibusdam consectetur. Maxime quidem et sapiente rerum. Minima soluta tempora voluptatem dolores. Eaque quia harum placeat. Aliquid suscipit placeat similique aut natus magni. Voluptas repellendus et ea est rem voluptate aut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...